SGMT (STOCKS)
Sagimet Biosciences Inc. Series A Common Stock
$5.160000
-0.090000 (-1.71%)
Prev close: $5.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David A. Happel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $167.65M
- Employees
- 14
- P/E (TTM)
- -2.88
- P/B (TTM)
- 1.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.40 | $-0.39 | -0.0067 | -1.70% |
|
Jun 2025 (Q2)
|
$-0.32 | $-0.52 | +0.1976 | +38.18% |
|
Mar 2025 (Q1)
|
$-0.56 | $-0.68 | +0.1192 | +17.55% |
|
Dec 2024 (Q4)
|
$-0.50 | $-0.63 | +0.1337 | +21.10% |